Oliver Pohl DVM, MPH, MSc, ERT, PMP, PCTM, PCB

Dr. Pohl is Head of Development at STALICLA. Oliver is leading the non-clinical, pre-clinical, CMC, clinical pharmacology, and regulatory development strategy and directs all related activities relying on a team of seasoned drug development professionals and consultants.